Brief: Astrazeneca Pharma India Says BSE And NSE Have Imposed A Fine Of 217,120 Rupees Each On Co
23/02/2024 15:34
Feb 23 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* ASTRAZENECA PHARMA INDIA - BSE AND NSE HAVE IMPOSED A
FINE OF
217,120 RUPEES EACH ON CO
Source text for Eikon: ID:nNSE36qQzl
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication